Subscribe

RSS Feed (xml)

Powered By

Skin Design:
Free Blogger Skins

Powered by Blogger

Tuesday, June 9, 2009

Selegline in Parkinson's Disease Treatment

Some neurologists still support the use of selegline (deprenyl) early in the treatment of Parkinson's disease.1 The early promise of neuroprotection from deprenyl may have been illusory, points out a new book, however deprenyl is still prescribed by some doctors for early Parkinson's and it is still an effecive MAO-B inhibitor.2

References
  1. Parkinson's Disease: Diagnosis and Clinical Management. Stewart A. Factor, William J. Weiner. Demos Medical Publishing; 2nd edition, 2008; pp. 496-497.
  2. Parkinson's disease and movement disorders: diagnosis and treatment guidelines for the practicing physician. Charles H. Adler, J. Eric Ahlskog. Humana Press, 2000; p. 111.

No comments: